Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love Zumiez Inc. (ZUMZ)?

Page 1 of 2

Zumiez Inc. (NASDAQ:ZUMZ) shareholders have witnessed an increase in activity from the world’s largest hedge funds in recent months.

In the financial world, there are tons of gauges shareholders can use to analyze the equity markets. A couple of the most innovative are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite hedge fund managers can outperform their index-focused peers by a very impressive margin (see just how much).

Zumiez Inc. (NASDAQ:ZUMZ)

Just as important, positive insider trading sentiment is another way to break down the stock market universe. As the old adage goes: there are lots of reasons for a corporate insider to get rid of shares of his or her company, but just one, very simple reason why they would behave bullishly. Plenty of empirical studies have demonstrated the impressive potential of this method if shareholders know what to do (learn more here).

Now, let’s take a peek at the latest action surrounding Zumiez Inc. (NASDAQ:ZUMZ).

What have hedge funds been doing with Zumiez Inc. (NASDAQ:ZUMZ)?

In preparation for this quarter, a total of 9 of the hedge funds we track were long in this stock, a change of 13% from the first quarter. With the smart money’s capital changing hands, there exists a select group of key hedge fund managers who were boosting their holdings meaningfully.

Of the funds we track, Tiger Consumer Management, managed by Patrick McCormack, holds the most valuable position in Zumiez Inc. (NASDAQ:ZUMZ). Tiger Consumer Management has a $24.6 million position in the stock, comprising 1% of its 13F portfolio. Sitting at the No. 2 spot is Royce & Associates, managed by Chuck Royce, which held a $16 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Other hedgies with similar optimism include Ken Griffin’s Citadel Investment Group, SAC Subsidiary’s Sigma Capital Management and Glenn Russell Dubin’s Highbridge Capital Management.

As one would reasonably expect, some big names have been driving this bullishness. Sigma Capital Management, managed by SAC Subsidiary, initiated the most outsized position in Zumiez Inc. (NASDAQ:ZUMZ). Sigma Capital Management had 1.4 million invested in the company at the end of the quarter. Israel Englander’s Millennium Management also made a $1 million investment in the stock during the quarter. The only other fund with a brand new ZUMZ position is Ken Gray and Steve Walsh’s Bryn Mawr Capital.

Insider trading activity in Zumiez Inc. (NASDAQ:ZUMZ)

Insider trading activity, especially when it’s bullish, is most useful when the company in question has experienced transactions within the past 180 days. Over the latest six-month time period, Zumiez Inc. (NASDAQ:ZUMZ) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Zumiez Inc. (NASDAQ:ZUMZ). These stocks are Barnes & Noble, Inc. (NYSE:BKS), American Greetings Corporation (NYSE:AM), United Online, Inc. (NASDAQ:UNTD), Titan Machinery Inc. (NASDAQ:TITN), and Brown Shoe Company, Inc. (NYSE:BWS). This group of stocks are in the specialty retail, other industry and their market caps resemble ZUMZ’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!